Cargando…
Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer
BACKGROUND: Gastric cancer (GC) is one of the most common types of malignancy and is associated with high morbidity and mortality rates around the world. With poor clinical outcomes, potential biomarkers for diagnosis and prognosis are important to investigate. OBJECTIVE: The aim of this study is to...
Autores principales: | Liao, Ping, Li, Wei, Liu, Ruizheng, Teer, Jamie K, Xu, Biaobo, Zhang, Wei, Li, Xi, Mcleod, Howard L, He, Yijing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199229/ https://www.ncbi.nlm.nih.gov/pubmed/30410354 http://dx.doi.org/10.2147/OTT.S173934 |
Ejemplares similares
-
FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics
por: Li, Li, et al.
Publicado: (2019) -
Prognostic role of SPARC expression in gastric cancer: a meta-analysis
por: Wang, Zishu, et al.
Publicado: (2014) -
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer
por: Shan, Zexing, et al.
Publicado: (2021) -
Change of SPARC expression after chemotherapy in gastric cancer
por: Gao, Yong-Yin, et al.
Publicado: (2015) -
Global transcriptomic analysis identifies SERPINE1 as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer
por: Xu, Bodong, et al.
Publicado: (2019)